NCT05845957

Brief Summary

Summary Aim: This research was conducted to determine the effectiveness of education given to students using digital storytelling in safe pediatric intravenous drug administration. Method: It is a randomized controlled experimental study. The sample of the study consisted of 84 nursing students. The students included in the study were divided into two equal groups: the experimental and control groups. Digital education material of the experimental group and theoretical education was applied to the control group. Before and after the training, a post-knowledge test was made and evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 8, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 6, 2023

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

April 17, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
Last Updated

May 6, 2023

Status Verified

May 1, 2023

Enrollment Period

5 months

First QC Date

April 17, 2023

Last Update Submit

May 4, 2023

Conditions

Keywords

Nursing studentsEducationDigital stroytellingpediatricssafe drug application

Outcome Measures

Primary Outcomes (1)

  • Statistical difference between groups about knowledge test scores

    Safe pediatric drug practices knowledge test is applied twice as pre-test and post-test in experimental and control groups. Safe pediatric drug practices knowledge test: It is a 17-question form prepared by researchers. Content validity has been made for the form. Each correct answer is calculated as 1 point and each wrong answer is calculated as 0 points. The higher the score obtained from the questionnaire, the higher the level of knowledge.

    During the education, approximately 25 minutes

Study Arms (2)

Digital Education Group

EXPERIMENTAL

All participants in this group were given the "Safe pediatric intravenous drug administration knowledge test" prepared by the researchers as a pre-test. The participants of this group, who were determined by randomization, were given training prepared using the digital storytelling method. The training took 25 minutes. After the training, the "Safe intravenous drug administration knowledge test" was applied as a post-test.

Other: Digital Education Group

Control Group

NO INTERVENTION

No intervention was made. All participants in this group were given the "Safe pediatric intravenous drug administration knowledge test" prepared by the researchers as a pre-test. Afterward, theoretical information on the subject was given. After theoretical information, the "Safe intravenous drug administration knowledge test" was applied as a post-test.

Interventions

Providing training on safe pediatric intravenous drug administration with digital storytelling method

Digital Education Group

Eligibility Criteria

Age19 Years - 23 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being a student of the Department of Nursing
  • Taking the child health and diseases nursing course and being successful
  • Volunteering to participate in the research

You may not qualify if:

  • Participate and quit the study
  • Being a 1st and 2nd year nursing student
  • Failure of the child health and diseases nursing course

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Semih

Izmir, 35665, Turkey (Türkiye)

Location

Study Officials

  • Semih Akkoyun

    Izmir Bakircay University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The research was a randomized controlled, experimental study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

April 17, 2023

First Posted

May 6, 2023

Study Start

December 8, 2021

Primary Completion

April 30, 2022

Study Completion

April 6, 2023

Last Updated

May 6, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

The study will be prepared for publication

Locations